The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...
Because the drug doesn’t target the brain, it has less potential for addiction. Learn why this could help the opioid crisis.
Fact checked by Nick Blackmer The Food and Drug Administration (FDA) on Thursday approved Journavx (suzetrigine), a new non-opioid painkiller that promises to be nonaddictive. Journavx is approved to ...
Friday closed down -0.50%, the Dow Jones Industrials Index ($DOWI) (DIA) closed down -0.75%, and the Nasdaq 100 Index ($IUXX) ...
Sen. Angela Alsobrooks (D-Md.) on Thursday grilled Department of Health and Human Services secretary nominee Robert F. Kennedy Jr. on his history of claiming Black Americans have a better immune ...